Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patients.

Scientific reports - 28 Dec 2024

Zhang Xianlu, Hu Jiyuan, Zheng Haoyuan, Ren Jiayi, Mu Siyu, Chen Yiming, Song Guoli, Chen Ya-Ang, Zhang Gejun

Abstract excerpt

To evaluate the predictive utility of N6-methyladenosine (m6A)-associated long non-coding RNAs (lncRNAs) for the prognosis and immunotherapy response in papillary renal cell carcinoma (pRCC). Transcriptomic data of pRCC samples were extracted from the TCGA database. The m6A-related lncRNAs were identified by Pearson correlation analysis. Univariate and LASSO regression analyses were used to develop a risk model....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Cell Proliferation

Share to Gene Expression Regulation, Neoplastic

Share to Kidney Neoplasms

Share to Nomograms

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 39732963
DOI: 10.1038/s41598-024-83263-0
PMCID: PMC11682231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patients.PMID 39732963Read ↗

Integrated analysis on m6A-related prognostic lncRNA signatures associated with prognosis and tumor immunotherapy in renal papillary cell carcinomaSemantic proximity Read ↗

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinomaSemantic proximity Read ↗

N6-methyladenosine-related lncRNAs as a biomarker for predicting the prognosis and immune microenvironment of clear cell renal cell carcinomaSemantic proximity Read ↗

Long non‑coding RNAs as prognostic biomarkers in papillary renal cell carcinomaSemantic proximity Read ↗

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Prognostic characteristics and immune infiltration analysis of Kidney Renal Clear Cell Carcinoma based on m6A- associated lncRNASemantic proximity Read ↗

N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing dataSemantic proximity Read ↗

N6-Methylandenosine-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

The Correlation Between Novel Survival-related Alternative Splicing Signature and Prognostic Prediction and Immune Microenvironment in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

The role of m6A RNA methylation-related lncRNAs in the prognosis and tumor immune microenvironment of papillary thyroid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.